EligibleTrials

Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma

Recruiting · NCT07354009 · Interventional (participants receive a specific treatment) · Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

PHACO+PC-IOLPHACO+PC-IOL+iStent

What this trial is about

To evaluate the efficacy and safety of istent inject W in reducing intraocular pressure in Chinese adult patients with open-angle glaucoma complicated with cataract.

Who can take part

Age range
18 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.